Trends in the Treatment of Ductal Carcinoma In Situ of the Breast
暂无分享,去创建一个
Beth A Virnig | Todd M Tuttle | Sara Durham | T. Tuttle | B. Virnig | N. Baxter | S. Durham | Nancy N. Baxter
[1] B. Cady. New diagnostic, staging, and therapeutic aspects of early breast cancer , 1990, Cancer.
[2] S. Schnitt,et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. , 1988, The New England journal of medicine.
[3] S. Edge,et al. Patterns of radiation use as a component of breast conservation therapy for noninvasive and invasive breast cancers in united states national comprehensive cancer network (nccn) centers , 2003 .
[4] J. Peterse,et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 , 2000, The Lancet.
[5] J. Gurwitz,et al. Use of breast-conserving surgery for treatment of stage I and stage II breast cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Cody,et al. Point: sentinel lymph node biopsy is indicated for patients with DCIS. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] R. Cote,et al. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies1 , 2001 .
[8] B Fisher,et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.
[9] S. Schnitt,et al. Treatment selection in ductal carcinoma in situ. , 2000, JAMA.
[10] P. Lantz,et al. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. , 2001, Journal of women's health & gender-based medicine.
[11] G. Sakorafas,et al. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. , 2000, Cancer treatment reviews.
[12] J. Houghton. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.
[13] G. Murphy,et al. Noninvasive Breast Carcinoma: Results of a National Survey by the American College of Surgeons , 1980, Annals of surgery.
[14] F. Gilliland,et al. Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non‐Hispanic white women in New Mexico, 1973–1994 , 1999, Cancer.
[15] K. Kerlikowske,et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.
[16] J. Cawson,et al. Axillary dissection and ductal carcinoma in situ of the breast: a change in practice. , 2000, The Australian and New Zealand journal of surgery.
[17] Roy A Jensen,et al. Ductal Carcinoma In Situ of the Breast: Impact of Pathology on Therapeutic Decisions , 2003, The American journal of surgical pathology.
[18] S. Edge,et al. Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.
[19] J Costantino,et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.
[20] V. Shavers,et al. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.
[21] K. Kerlikowske,et al. Incidence of and treatment for ductal carcinoma in situ of the breast. , 1996, JAMA.
[22] K I Bland,et al. The National Cancer Data Base 10‐year survey of breast carcinoma treatment at hospitals in the United States , 1998, Cancer.
[23] M. Silverstein,et al. Sentinel Node Biopsy for Patients With DCIS: A Dangerous and Unwarranted Direction , 2001, Annals of Surgical Oncology.
[24] D. Winchester,et al. National treatment trends for ductal carcinoma in situ of the breast. , 1997, Archives of surgery.
[25] A. Legorreta,et al. Axillary node dissection in ductal carcinoma in situ. , 1998, American journal of clinical oncology.
[26] E. Fisher,et al. Avoiding the unintended consequences of growth in medical care: how might more be worse? , 1999, JAMA.
[27] N. Wolmark,et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.
[28] S. Singletary,et al. Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS) , 2002, CA: a cancer journal for clinicians.
[29] J. Pierce,et al. Regional differences in the incidence and treatment of carcinoma in situ of the breast. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[30] K. Kerlikowske,et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. , 2000, Archives of internal medicine.
[31] Katherine L Kahn,et al. Validity of cancer registry data for measuring the quality of breast cancer care. , 2002, Journal of the National Cancer Institute.
[32] D. Winchester,et al. Treatment trends for ductal carcinoma in situ of the breast , 1995, Annals of Surgical Oncology.
[33] M. Moore,et al. Treatment of ductal carcinoma in situ of the breast. , 1991, Seminars in surgical oncology.
[34] G. Schwartz. The Current Treatment of Ductal Carcinoma in Situ , 2001, The breast journal.